194 related articles for article (PubMed ID: 9448829)
1. Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses.
Piercy RJ; Swardson CJ; Hinchcliff KW
J Am Vet Med Assoc; 1998 Jan; 212(2):244-7. PubMed ID: 9448829
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
3. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs.
Randolph JF; Stokol T; Scarlett JM; MacLeod JN
Am J Vet Res; 1999 May; 60(5):636-42. PubMed ID: 10328437
[TBL] [Abstract][Full Text] [Related]
4. Quantitative studies of erythropoiesis in the clinically normal, phlebotomized, and feline leukemia virus-infected cat.
Wardrop KJ; Kramer JW; Abkowitz JL; Clemons G; Adamson JW
Am J Vet Res; 1986 Oct; 47(10):2274-7. PubMed ID: 3022625
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
[TBL] [Abstract][Full Text] [Related]
6. Reticulocyte changes after experimental anemia and erythropoietin treatment of horses.
Cooper C; Sears W; Bienzle D
J Appl Physiol (1985); 2005 Sep; 99(3):915-21. PubMed ID: 16103516
[TBL] [Abstract][Full Text] [Related]
7. A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.
Quinn J; Fisher PW; Capocasale RJ; Achuthanandam R; Kam M; Bugelski PJ; Hrebien L
Cytometry A; 2007 Aug; 71(8):612-24. PubMed ID: 17542025
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant hematopoietins on blood-loss anemia in mice.
Jones KB; Anderson DW; Longmore GD
Iowa Orthop J; 2005; 25():129-34. PubMed ID: 16089085
[TBL] [Abstract][Full Text] [Related]
9. Using red blood cell creatine concentration to evaluate the equine erythropoietic response.
Wu MJ; Feldman BF; Zinkl JG; Jain NC
Am J Vet Res; 1983 Aug; 44(8):1427-32. PubMed ID: 6625293
[TBL] [Abstract][Full Text] [Related]
10. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies against human recombinant erythropoietin: an unusual cause of erythropoietin resistance].
Virón B; Kolta A; Kiladjian JJ; Mignon F; Mayeux P; Casadevall N
Nephrologie; 2002; 23(1):19-22. PubMed ID: 11887573
[TBL] [Abstract][Full Text] [Related]
12. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Krafft A; Bencaiova G; Breymann C
Fetal Diagn Ther; 2009; 25(2):239-45. PubMed ID: 19506383
[TBL] [Abstract][Full Text] [Related]
13. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
14. Reduction of erythroid progenitors in protein-energy malnutrition.
Borelli P; Blatt S; Pereira J; de Maurino BB; Tsujita M; de Souza AC; Xavier JG; Fock RA
Br J Nutr; 2007 Feb; 97(2):307-14. PubMed ID: 17298699
[TBL] [Abstract][Full Text] [Related]
15. Response to recombinant human erythropoietin in patients with myelodysplastic syndromes.
Stasi R; Brunetti M; Bussa S; Conforti M; Di Giulio C; Crescenzi A; Terzoli E; Vecchione A; Pagano A
Clin Cancer Res; 1997 May; 3(5):733-9. PubMed ID: 9815743
[TBL] [Abstract][Full Text] [Related]
16. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria.
Balleari E; Gatti AM; Mareni C; Massa G; Marmont AM; Ghio R
Haematologica; 1996; 81(2):143-7. PubMed ID: 8641643
[TBL] [Abstract][Full Text] [Related]
18. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
[TBL] [Abstract][Full Text] [Related]
19. [In vitro and in vivo studies of murine erythropoietic recovery after treatment with cyclophosphamide].
Aguirre MV; Juaristi JA; Alba Alvarez M; Carmuega RJ; Brandan NC
Sangre (Barc); 1999 Jun; 44(3):182-7. PubMed ID: 10481578
[TBL] [Abstract][Full Text] [Related]
20. Anemia of inflammatory disease in the dog: ferrokinetics of adjuvant-induced anemia.
Feldman BF; Kaneko JJ; Farver TB
Am J Vet Res; 1981 Apr; 42(4):583-5. PubMed ID: 7332115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]